E72.5 Disorders of glycine metabolism

Name of the Condition

• Disorders of glycine metabolism (ICD-10 Code: E72.5)

Summary

Disorders of glycine metabolism are rare genetic conditions affecting the body’s ability to process glycine, a non-essential amino acid involved in protein synthesis, neurotransmission, and metabolic pathways. These disorders disrupt normal glycine metabolism, leading to abnormal accumulation or deficiency of glycine or its byproducts. Clinical effects vary but may involve neurological, hepatic, or renal impairment, depending on the underlying defect.

Causes

These disorders are primarily caused by genetic mutations that impair enzymes or transport proteins involved in glycine metabolism. Most are inherited in an autosomal recessive pattern, requiring two mutated copies of a gene for the condition to manifest. The mutations disrupt biochemical pathways, resulting in abnormal glycine levels or toxic byproduct accumulation.

Risk Factors

• Family history of glycine metabolism disorders.
• Consanguinity (parents who are close relatives) increasing the likelihood of inheriting recessive mutations.
• Ethnic or geographic prevalence of specific genetic variants in certain populations.

Symptoms

• Neurological symptoms such as developmental delays, seizures, or intellectual disability.
• Gastrointestinal issues like vomiting, poor feeding, or failure to thrive.
• Hepatic or renal dysfunction in severe cases.

Diagnosis

Diagnosis typically involves clinical evaluation, biochemical testing (e.g., measuring glycine levels in blood or urine), and genetic testing to identify mutations. Additional tests may include imaging studies or metabolic profiling to assess organ function. A definitive diagnosis relies on correlating clinical findings with laboratory results and genetic confirmation.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. Options may include dietary modifications (e.g., restricted glycine intake), medications to reduce toxic byproducts, and supportive care for neurological or organ-related issues. Specific therapies depend on the underlying disorder and its severity.

Prognosis and Follow-Up

Prognosis varies based on the specific disorder and its severity. Early diagnosis and intervention can improve outcomes, but some forms may lead to long-term neurological or organ damage. Regular follow-up with metabolic specialists, monitoring of metabolic parameters, and developmental assessments are typically recommended.

Complications

Potential complications include progressive neurological impairment, organ dysfunction (e.g., liver or kidney damage), and developmental delays. Severe cases may result in life-threatening metabolic crises if untreated.

Lifestyle & Prevention

Lifestyle modifications may include adhering to prescribed dietary restrictions and avoiding triggers that exacerbate symptoms. Genetic counseling is recommended for families to understand recurrence risks and options for future pregnancies.

When to Seek Professional Help

Seek medical attention if symptoms such as seizures, developmental delays, or unexplained vomiting occur, especially in infants or young children. Prompt evaluation is critical to prevent irreversible damage.

Tips for Medical Coders

Document the specific subtype of glycine metabolism disorder (e.g., nonketotic hyperglycinemia) when available, as this may impact coding specificity. Ensure clinical documentation supports the diagnosis, including relevant lab results or genetic findings. Code E72.5 is appropriate for disorders of glycine metabolism without further specification, but additional codes may be required for associated manifestations or complications.